News

They have also signed a new co-promotion agreement for the investigational drug tofacitinib, formerly known as tasocitinib, which is being studied for multiple inflammatory conditions, including RA, in

Besides cGMP (current good manufacturing practices) manufacturing, Avecia Biotechnology ‘s services also include the development of analytical methods, process validation, stability studies, quality control, and regulatory support for

Pre-configured with the Torrent Suite Software, the scalable computing platform converts raw signal into base calls in less than an hour and delivers the data to the end

The Cancer Vaccine Acceleration Fund (CVAF) – a joint initiative between the Cancer Research Institute and the Ludwig Institute for Cancer Research – has completed a new investment

Almost $1.7bn charges before taxes were due to a setback for its experimental blood clot preventer vorapaxar. However, Merck beat forecasts on strong sales growth from its key

Pfizer CEO Ian Read announced slashing the drug maker’s research budget by a third to $6.5bn to $7bn over the next two years, bloomberg.com reported. Meanwhile, Merck CEO

Further, the stronger Japanese currency has also eaten into the value of overseas revenue. Takeda‘s net income dropped to JPY215.5bn from JPY259.1bn year earlier. Sales fell 4.2% to

The CRADA will allow the WRAIR to conduct preclinical testing on a novel compound derived from Concert’s DCE Platform (deuterated chemical entity platform) for seizure protection associated with

Both studies were 12-week, double-blinded, placebo-controlled clinical trials conducted under the regulatory guidelines of Health Canada. Based on analysis of the data, both the primary and secondary efficacy